Traditional therapeutic support surfaces most often use a repeating pressure therapy pattern. A patient’s body easily adjusts to this over time, resulting in adaptation to the surface and a less beneficial outcome. Airisana™ seeks to reduce this risk and promote sustained pressure reduction by randomized pressure therapy modes and programming that combine the benefits of multiple pressure therapies in one surface.
The consistent airflow and whole-body even spread of traditional therapeutic support surfaces can excessively dry or over-cool the patient’s skin where unnecessary. Airisana™ uses unique valve technology to target airflow delivery where the highest pressure is indicated, giving therapy where it’s needed most.
Interdisciplinary care collaboration, such as respiratory therapy or physical therapy, is essential to apply a wholistic care approach as part of the prevention of and reduction in the risk of pressure injuries or additional acquired conditions leading to an extended hospital stay. Many air surfaces may not safely support bedside therapies without risk. Airisana™ is designed to safely facilitate bedside therapy with stable and supportive side perimeters that are intended to aid in these care activities, rather than standing in the way of the multiple care disciplines one patient often needs. The firm stabilized perimeter and supportive foam base can also make Airisana ready even for emergencies, with a simple, quick access hose connection for disconnection or rapid attachment, as well as a CPR deflate function.
A therapeutic support surface shouldn’t get in the way of hands-on care. Airisana™ was designed to allow care staff to reposition the patient on the surface, while they provide oversight at bedside. This gentle turn is intended to reduce friction and shear risk, as well as prevent staff injuries often associated with the lifting and pulling that accompanies repositioning.
Even the most effective medical technologies are ineffective when no-one can afford them. Airisana™ desires to returns savings of more than 120% when purchased, compared to the cost of traditional, rented therapeutic support surfaces. When compared with many facilities’ average rental expenses, a return on investment is realized within 2-3 months. Further, the facility may be impacted through reduced reimbursement, increased risks of litigation, and overall costs from managing multiple surfaces and the time to place at-risk patients on a treatment surface.